Treace Announces First Annual National Bunion Day
16. April 2024 07:00 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., April 16, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace to Report First Quarter 2024 Financial Results
09. April 2024 07:00 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., April 09, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace Celebrates 100,000 Lapiplasty® 3D Bunion Correction® Patient Milestone
25. März 2024 07:00 ET
|
Treace Medical Concepts, Inc.
Treace Further Expands Focus on Bunion Deformity Education by Sponsoring First-Ever National Bunion Day in the U.S. on April 16, 2024 Launches New “Future You” Patient Education and Brand...
Treace Medical Concepts Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Guidance
27. Februar 2024 16:05 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace to Report Fourth Quarter and Full-Year 2023 Financial Results
07. Februar 2024 16:05 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace Announces Interim 3-Year ALIGN3D™ Clinical Study Data at the 2024 ACFAS Scientific Conference Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure
02. Februar 2024 12:00 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace to Highlight Latest Product Innovations and ALIGN3D™ Study Outcomes at the 2024 ACFAS Annual Scientific Conference
01. Februar 2024 07:00 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2023 Revenue
08. Januar 2024 07:00 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace to Present at 42nd Annual J.P. Morgan Healthcare Conference
19. Dezember 2023 07:00 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Dec. 19, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace Medical Concepts Reports Third Quarter 2023 Financial Results
09. November 2023 16:05 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...